Suppr超能文献

复方新诺明对人体肾脏肌酐排泄的影响(作者译)

[Effect of Co-trimoxazole on renal creatinine excretion in man (author's transl)].

作者信息

Bräutigam M, Froese P, Baethke R, Kessel M

出版信息

Klin Wochenschr. 1979 Jan 15;57(2):95-6. doi: 10.1007/BF01491342.

Abstract

Clinical observations have shown, that administration of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) may result in an elevation of the serum-creatinine level. In 27 subjects the endogenous creatinine- and inulinclearance were measured before and during oral or parenteral application of Co-trimoxazole. The inulinclearance showed no significant differences (p greater than 0,05). But the endogenous creatinine clearance showed a reduction of 18% during the oral and of 13% during the parenteral treatment (p less than or equal to 0,05). These observations indicate a functional inhibition of the tubular creatinine secretion by Co-trimoxazole.

摘要

临床观察表明,服用复方新诺明(甲氧苄啶-磺胺甲恶唑)可能会导致血清肌酐水平升高。对27名受试者在口服或肠胃外应用复方新诺明之前及期间测量了内生肌酐清除率和菊粉清除率。菊粉清除率无显著差异(p大于0.05)。但内生肌酐清除率在口服治疗期间降低了18%,在肠胃外治疗期间降低了13%(p小于或等于0.05)。这些观察结果表明复方新诺明对肾小管肌酐分泌有功能抑制作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验